Quality Control Program and Its Results of Korean Society for Cytopathologists
![]() |
Lee, Hye-Kyung
(Department of Pathology Eulji University Hospital)
Kim, Sung-Nam (P&B Pathology Clinic) Khang, Shin-Kwang (Seoul Asan Medical Center) Kang, Chang-Suk (Yeouido St Mary Hospital) Yoon, Hye-Kyoung (Pusan Paik Hospital) |
1 | Hutchinson ML, Zahniser DJ, Sherman ME, et al. Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based studyconducted in a region of Costa Rica with a high incidence of cervical carcinoma. Cancer Cytopathol 1999; 87: 48-55 DOI |
2 | Davey DD, Neal MH, Wilbur DC, Colgan TJ, Styer PE, Mody DR. Bethesda 2001 implementation and reporting rates. 2003 practices of participants in the college of American pathologists interlaboratory comparison program in cervicovaginal cytology. Arch Pathol Lab Med 2004;128: 1224-29 |
3 | Davey DD, Naryshkin S, Nielsen ML, Kline TS. Atypical squamous cells of undetermined significance: interlaboratory comparison and quality assurance monitors. Diagn Cytopathol 1994; 11: 390-6 DOI ScienceOn |
4 | Joste NE, Crum CP, Cibas ES. Cytologic/histologic correlation for quality control in cervicovaginal cytology: experience with 1,582 cases. Am J Clin Pathol 1995; 103: 32-4 DOI |
5 | Kurman RJ, Solomon D. The Betheseda System for Reporting Cervical/Vaginal Cytologic Diagnoses: Definitions, Criteria, and Explanatory Notes for Terminology and Specimen Adequacy. New York, NY: Springer-Verlag; 1994 |
6 | Limaye A, Connor AJ, Huang X, Luff R. Comparative analysis of conventional Papanicolaou tests and a fluid-based thin-layer method. Arch Pathol Lab Med 2003; 127: 200-4 |
7 | Linder J, Zahniser D. ThinPrep Papanicolaou testing to reduce false-negative cervical cytology. Arch Pathol Lab Med 1998; 122: 139-44 |
8 | Raab SS, Zaleski MS, Thomas PA, et al. Telecytology:diagnostic accuracy in cervical-vaginal smears. Am J Clin Pathol 1996; 105: 599-603 DOI |
9 | Krieger P, Naryshkin S. Random re-screening of cytologic smears: a practical and effective component of quality assurance programs in both small and large laboratories. Acta Cytol 1994; 38: 291-8 |
10 | Jones BA, Novis DA. Cervical biopsy-cytology correlation: a College of American Pathologists Q-Probes study of 22,439 correlations in 348 laboratories. Arch Pathol Lab Med 1996; 120: 523-31 |
11 | Nagy GK. False negative rate. Acta Cytol 1997: 41: 778-80 DOI ScienceOn |
12 | Fidda N, Miron J, Rodgers WH, Rader A. Impact of the new Bethesda System 2001 on specimen adequacy of conventional cervicovaginal smears. Diagn Cytopathol 2004; 30: 235-9 DOI ScienceOn |
13 | Davey DD, Woodhouse S, Styer P, Stastny J, Mody D. Atypical epithelial cells and specimen adequacy: current laboratory practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med 2000; 124: 203-11 |
14 | Mody DR, Davey DD, Branca M, et al. Quality assurance and risk reduction guidelines. Acta Cytol 2000; 44: 496-507 DOI ScienceOn |
![]() |